Cidara Therapeutics, Inc.Cidara Therapeutics, Inc.Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc.

No trades
See on Supercharts

Price target

24.500.000.00%
The 2 analysts offering 1 year price forecasts for CDTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to CDTX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CDTX EPS for the last quarter is −19.99 USD despite the estimation of −4.10 USD. In the next quarter EPS is expected to reach −4.25 USD. Track more of Cidara Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Cidara Therapeutics, Inc. revenue is expected to reach ‪433.33 K‬ USD. Check out Cidara Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, CDTX price target is 24.50 USD with a max estimate of 25.00 USD and a min estimate of 24.00 USD. Check if this forecast comes true in a year, meanwhile watch Cidara Therapeutics, Inc. stock price chart and keep track of the current situation with CDTX news and stock market news.